MedPath

神基(珠海)制药有限公司

Ownership
-
Established
1997-04-08
Employees
-
Market Cap
-
Website
https://www.ucb.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Levetiracetam Oral Solution

Product Name
开浦兰/Keppra
Approval Number
国药准字H20247224
Approval Date
Oct 11, 2024
NMPA

Levetiracetam Tablets

Product Name
开浦兰/Keppra
Approval Number
国药准字H20227146
Approval Date
Oct 27, 2022
NMPA

Levetiracetam Tablets

Product Name
开浦兰/Keppra
Approval Number
国药准字H20227147
Approval Date
Oct 27, 2022
NMPA

Isosorbide Mononitrate Tablets

Product Name
单硝酸异山梨酯片
Approval Number
国药准字H20000520
Approval Date
Sep 30, 2010
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.